Stock Research: Zydus

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Zydus

NSI:ZYDUSLIFE INE010B01027
18
  • Value
    51
  • Growth
    5
  • Safety
    Safety
    65
  • Combined
    27
  • Sentiment
    32
  • 360° View
    360° View
    18
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Zydus Lifesciences Limited is an India-based global life sciences company focused on discovering, developing, manufacturing, and marketing healthcare therapies. Its main businesses include integrated pharmaceutical operations, active pharmaceutical ingredients (API), human formulations, animal health and veterinary products, and health and wellness products, with products like Lipaglyn and Ujvira. The company has a global presence, marketing products in the United States, India, Europe, and emerging markets. In the last fiscal year, the company had a market cap of $11341 million, profits of $1978 million, and revenue of $2720 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 67 67 75
Growth
5 41 35 19
Safety
Safety
65 79 49 47
Sentiment
32 83 88 26
360° View
360° View
18 93 82 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
18 23 38 13
Opinions Change
56 81 48 49
Pro Holdings
n/a 85 99 94
Market Pulse
43 92 79 15
Sentiment
32 83 88 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 67 67 75
Growth
5 41 35 19
Safety Safety
65 79 49 47
Combined
27 87 55 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
44 50 61 70
Price vs. Earnings (P/E)
57 73 68 74
Price vs. Book (P/B)
45 58 69 69
Dividend Yield
57 44 45 52
Value
51 67 67 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
26 18 20 22
Profit Growth
31 67 67 39
Capital Growth
5 31 12 66
Stock Returns
33 57 89 23
Growth
5 41 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
62 74 62 42
Refinancing
45 44 52 62
Liquidity
81 80 48 39
Safety Safety
65 79 49 47

Similar Stocks

Discover high‑ranked alternatives to Zydus and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: